- Home
- INVE vs YI Comparison
INVE vs YI Comparison
Compare INVE & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- YI
- Stock Information
- Founded
- INVE 1990
- YI 2010
- Country
- INVE United States
- YI China
- Employees
- INVE N/A
- YI N/A
- Industry
- INVE Computer peripheral equipment
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- INVE Technology
- YI Consumer Staples
- Exchange
- INVE Nasdaq
- YI Nasdaq
- Market Cap
- INVE 74.2M
- YI 70.0M
- IPO Year
- INVE 1997
- YI N/A
- Fundamental
- Price
- INVE $3.12
- YI $7.34
- Analyst Decision
- INVE Strong Buy
- YI
- Analyst Count
- INVE 3
- YI 0
- Target Price
- INVE $6.50
- YI N/A
- AVG Volume (30 Days)
- INVE 65.8K
- YI 13.5K
- Earning Date
- INVE 08-07-2025
- YI 06-19-2025
- Dividend Yield
- INVE N/A
- YI N/A
- EPS Growth
- INVE N/A
- YI N/A
- EPS
- INVE 3.12
- YI N/A
- Revenue
- INVE $25,239,000.00
- YI $1,984,717,013.00
- Revenue This Year
- INVE N/A
- YI N/A
- Revenue Next Year
- INVE $9.00
- YI N/A
- P/E Ratio
- INVE $1.01
- YI N/A
- Revenue Growth
- INVE N/A
- YI N/A
- 52 Week Low
- INVE $2.86
- YI $4.15
- 52 Week High
- INVE $4.35
- YI $12.90
- Technical
- Relative Strength Index (RSI)
- INVE 45.58
- YI 42.70
- Support Level
- INVE $3.10
- YI $6.65
- Resistance Level
- INVE $3.25
- YI $7.80
- Average True Range (ATR)
- INVE 0.12
- YI 0.48
- MACD
- INVE -0.00
- YI -0.09
- Stochastic Oscillator
- INVE 14.81
- YI 33.82
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.